, 11 tweets, 4 min read
My Authors
Read all threads
Looking forward to #ASH2019 in less than two weeks! Read the thread below for a list of 10 abstracts that I think offer new practice-changing insights, particularly for community oncologists . #leusm #mmsm
(1/10) Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
Abstract: ash.confex.com/ash/2019/webpr…
(2/10) Dara-KRd Induction, Autologous Transplantation and Post-Transplant, Response-Adapted, Measurable Residual Disease-Based Dara-Krd Consolidation in Patients with Newly Diagnosed Multiple Myeloma
Abstract: ash.confex.com/ash/2019/webpr…
(3/10) Randomized Trial of Lenalidomide + Dexamethasone vs. Clarythromycin, Lenalidomide + Dexamethasone As 1st Line Treatment in Pts w/ Multiple Myeloma Not Candidates for Autologous Stem Cell Transplantation
Abstract: ash.confex.com/ash/2019/webpr…
(4/10) Treatment of Primary Plasma Cell Leukemia with Carfilzomib and Lenalidomide-Based Therapy: Results of the First Interim Analysis of the Phase 2 EMN12/HOVON129 Study
Abstract: ash.confex.com/ash/2019/webpr…
(5/10) Evaluation of the Prognostic Value of PET-CT at Diagnosis and Follow-up in Transplant-Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients Treated in the Phase 3 Cassiopeia Study
Abstract: ash.confex.com/ash/2019/webpr…
(6/10) Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (Ixa Dara dex) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients
Abstract: ash.confex.com/ash/2019/webpr…
(7/10) Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple Myeloma
Abstract: ash.confex.com/ash/2019/webpr…
(8/10) DARA Maintenance Therapy Improves Depth of Response and Results in Durable PFS Following Dara Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) Induction Therapy in Multiple Myeloma: Update of the Lyra Study
Abstract: ash.confex.com/ash/2019/webpr…
(9/10) Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
Abstract: ash.confex.com/ash/2019/webpr…
(10/10) Depth of Response to Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone Improves over Time in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma: Griffin Study Update
Abstract: ash.confex.com/ash/2019/webpr…
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with Dr. Suzanne Lentzsch

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!